Cargando…
OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
BACKGROUND: OnabotulinumtoxinA has been widely used for control of chronic migraine. The aim of the current study was to evaluate the efficacy of different doses of the onabotulinumtoxinA therapy in patients with chronic migraine. METHODS: This is a retrospective paired comparison study on patients...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190093/ https://www.ncbi.nlm.nih.gov/pubmed/35698027 http://dx.doi.org/10.1186/s12883-022-02742-x |